title: CpG island methylation of tumor-related genes in three primary central nervous system lymphomas in immunocompetent patients.
abstract: We have determined the promoter CpG island methylation status of O(6)-methylguanine-DNA methyltransferase (MGMT), glutathione-S-transferase P1 (GSTP1), death-associated protein kinase (DAPK), p14(ARF), thrombospondin-1 (THBS1), tissue inhibitor of metalloproteinase-3 gene (TIMP-3), p73, p16(INK4A), RB1, and TP53 genes in three primary central nervous system lymphomas (PCNSL). Five genes (GSTP1, DAPK, TIMP-3, p16(INK4A), and RB1) were hypermethylated in two samples, whereas MGMT, THBS1, and p73 were aberrantly methylated in only one sample. No case presented CpG island methylation for the p14(ARF) and TP53 genes. These findings concur with previous data suggesting a frequent inactivation of p16(INK4A) and very limited involvement of TP53 in PCNSL and also provide insights into the epigenetic molecular involvement of other tumor-related genes in this neoplasm.
authors.affiliation: Department of Experimental Surgery, Laboratorio de Oncogenetica Molecular, Hospital Universitario La Paz, Paseo Castellana 261, 28046 Madrid, Spain.
authors.forename: Pilar
authors.initials: P
authors.lastname: Gonzalez-Gomez
authors.forename: M Josefa
authors.initials: MJ
authors.lastname: Bello
authors.forename: Dolores
authors.initials: D
authors.lastname: Arjona
authors.forename: M Eva
authors.initials: ME
authors.lastname: Alonso
authors.forename: Jesus
authors.initials: J
authors.lastname: Lomas
authors.forename: Cinthia
authors.initials: C
authors.lastname: Amiñoso
authors.forename: Jose M
authors.initials: JM
authors.lastname: de Campos
authors.forename: Jose L
authors.initials: JL
authors.lastname: Sarasa
authors.forename: Manuel
authors.initials: M
authors.lastname: Gutierrez
authors.forename: Juan A
authors.initials: JA
authors.lastname: Rey
mesh_terms: D000368:Aged; D051017:Apoptosis Regulatory Proteins; D001921:Brain / Q000502:physiology; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000235:genetics; D016543:Central Nervous System Neoplasms / Q000235:genetics*; D018899:CpG Islands; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000235:genetics; D019175:DNA Methylation; D004268:DNA-Binding Proteins / Q000235:genetics; D064550:Death-Associated Protein Kinases; D005260:Female; D016147:Genes, Tumor Suppressor; D016158:Genes, p53; D051549:Glutathione S-Transferase pi; D005982:Glutathione Transferase / Q000235:genetics; D006801:Humans; D007121:Immunocompetence; D007527:Isoenzymes / Q000235:genetics; D008223:Lymphoma / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009687:Nuclear Proteins / Q000235:genetics; D019853:O(6)-Methylguanine-DNA Methyltransferase / Q000235:genetics; D011401:Promoter Regions, Genetic; D012016:Reference Values; D016160:Retinoblastoma Protein / Q000235:genetics; D019700:Thrombospondin 1 / Q000235:genetics; D019717:Tissue Inhibitor of Metalloproteinase-3 / Q000235:genetics; D000072160:Tumor Protein p73; D025803:Tumor Suppressor Protein p14ARF / Q000235:genetics; D025521:Tumor Suppressor Proteins
chemical_list: D051017:Apoptosis Regulatory Proteins; D019941:Cyclin-Dependent Kinase Inhibitor p16; D004268:DNA-Binding Proteins; D007527:Isoenzymes; D009687:Nuclear Proteins; D016160:Retinoblastoma Protein; C000606460:TP73 protein, human; D019700:Thrombospondin 1; D019717:Tissue Inhibitor of Metalloproteinase-3; D000072160:Tumor Protein p73; D025803:Tumor Suppressor Protein p14ARF; D025521:Tumor Suppressor Proteins; D019853:O(6)-Methylguanine-DNA Methyltransferase; C496556:GSTP1 protein, human; D051549:Glutathione S-Transferase pi; D005982:Glutathione Transferase; D064550:Death-Associated Protein Kinases; D017871:Calcium-Calmodulin-Dependent Protein Kinases